Xencor Inc Revenue per Employee (XNCR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xencor Inc  (NASDAQ: XNCR)
 

Xencor Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 454.88% in the third quarter 2026, year on year to cumulative value of $200 million, Xencor Inc's revenue per employee grew on a trailing twelve months basis to $ 771,131. The productivity of Xencor Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 259 other companies have achieved higher revenue per employee. While Xencor Inc's total ranking has deteriorated compared to the previous quarter from 1399 to 2123. Xencor Inc has 260 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XNCR Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 454.88 % 17.46 % -86.2 % -46.51 % 18 %
Sales per Employee (TTM) $ 771,131 403,742 374,462 482,985 577,431
XNCR's Total Ranking # 2123 # 1399 # 1193 # 1181 #
Seq. Revenue Change 127.48 % 1034.21 % -84.01 % 34.47 % -51.85 %

XNCR Company Profile >> Back to XNCR Efficiency Comparisons >> Compare XNCR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 126
Healthcare Sector # 260
Overall Market # 2123

Revenue per Employee Statistics
High Average Low
$ 1,256,312 $ 474,152 $ 33,950
(Mar 31 2022)   (Mar 31 2015)



Financial Statements
Xencor Inc's Revenue MRQ $ 117 Millions Visit XNCR's Income Statement
Xencor Inc's Revenues TTM $ 200 Millions Visit XNCR's aggregate revenue growth
What are XNCR's Sales? Visit XNCR's Sales by Segment




Other Ratios
Xencor Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XNCR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XNCR's Competitors
Revenue per Employee for XNCR's Suppliers
Revenue per Employee for XNCR's Customers

You may also want to know
XNCR's Sales Growth Rates XNCR's Pe Price to earnings ratio XNCR's Receivables Turnover Ratio XNCR's Stock Quote
XNCR's Net Income Growth Rates XNCR's Ps Price to Sales ratio XNCR's Sales per Employee XNCR's Asset Turnover Ratio
XNCR's Net Margin XNCR's Pb Price to Book ratio XNCR's Financial Strength Ratios XNCR's Dividend Payout Ratio
Date modified: 2026-11-05T09:18:09+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.